石藥集團（０１０９３）產品ＳＹＨ２０４６片獲美國批准臨床試驗

　　《經濟通通訊社１２日專訊》石藥集團（０１０９３）公布，ＳＹＨ２０４６片獲得美國食
品藥品監督管理局批准在美國開展臨床試驗。
　
　　該集團指，ＳＹＨ２０４６片獲批適應症為急性心肌梗死後心力衰竭，臨床前研究表明該產
品可改善心臟功能，具較高安全性。（ｗｈ）

送禮活動浪接浪！想緊貼著數活動消息？即Like etnet Facebook專頁！► 立即讚好

下一篇新聞︰08/05/2025 09:37 《異動股》慧居科技等２家公司上午９：３６異動

其他相關新聞

12/05/2025 12:45 《午市前瞻》恒指已修復關稅跌幅值博率偏低，藥股風險只升不降

12/05/2025 12:07 恒指半日升２１２點報２３０７９，出口股強勁藥股遭意外衝擊

12/05/2025 09:31 《異動股》石藥集團等５家藍籌上午９：３０異動

07/05/2025 16:12 高位蒸發五百點恒指收市僅升２９點，領展升７％，藥明生物跌７％

06/05/2025 16:12 恒指全日升１５８點報２２６６２，農夫山泉升７％，周大福升６％

備註：	即時報價更新時間為13/05/2025 18:00
	港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站

經濟通
強化版MQ
強化版TQ
財曆
Mobile
Web

客務熱線︰(852) 2880 7004 客務郵箱︰cs@etnet.com.hk
關於我們 | 產品服務 | 廣告查詢 | 聯絡我們 | 私隱政策 | 使用條款 | 網站導航 | 有用連結 | RSS新聞

Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.

《經濟通》所刊的署名及／或不署名文章，相關內容屬作者個人意見，並不代表《經濟通》立場，《經濟通》所扮演的角色是提供一個自由言論平台。